Telomium is a biotechnology company developing a therapeutic product for cancer immunotherapy.
Our first-in-class ribonucleoprotein vaccine has the ability to mimic a viral attack and induce an auto-immune reaction targeted against any form of cancer, without causing significant side effects. This self-vectored and self-adjuvanted vaccine is prepared from a patented, safe, competitive and scalable yeast-based technology using a breakthrough innovation in the production of recombinant telomerase.
Today, we are actively looking for funding to finance a Clinical Phase I/Phase II trial in humans.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Ivry Sur Seine
- Industry
- Biotechnology
- Website
- http://www.telomium.com/
- Keywords
- Cancer, Immunotherapy, Oncology, Telomerase.
- HQ
- IVRY SUR SEINE
Telomium Questions
Telomium's website is http://www.telomium.com/
Telomium's LinkedIn profile is https://fr.linkedin.com/company/telomium
Telomium has
1 employees.
View email and phone details for 1
employees at Telomium.
Telomium's industry is
Biotechnology
Telomium's top competitors are
Amgen,
Roche,
Vaxon Biotech,
Inovactis,
Baliopharm Ag,
Novithera,
Gilead Sciences,
Takeda,
Biomunex Pharmaceuticals,
Neurophoenix.
Telomium's categories are Biotechnology
Telomium's founding year is 2016
